| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AGIOS PHARMACEUTICALS INC | 1,930,369 | 136,265,000 | 85.66% | ||
| 2 | SERES THERAPEUTICS INC | 599,297 | 17,763,000 | 11.17% | ||
| 3 | ELEVEN BIOTHERAPEUTICS INC | 1,907,008 | 4,596,000 | 2.89% | ||
| 4 | RENEWABLE ENERGY | 32,331 | 268,000 | 0.17% | ||
| 5 | BG Medicine, Inc. | 441,072 | 181,000 | 0.11% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-011952, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
